JP2023535232A5 - - Google Patents
Info
- Publication number
- JP2023535232A5 JP2023535232A5 JP2023512465A JP2023512465A JP2023535232A5 JP 2023535232 A5 JP2023535232 A5 JP 2023535232A5 JP 2023512465 A JP2023512465 A JP 2023512465A JP 2023512465 A JP2023512465 A JP 2023512465A JP 2023535232 A5 JP2023535232 A5 JP 2023535232A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010704946.1 | 2020-07-21 | ||
| CN202010704946.1A CN113952471A (zh) | 2020-07-21 | 2020-07-21 | 用于治疗眼部疾病的组合物和方法 |
| CN202110378979.6 | 2021-04-08 | ||
| CN202110378979 | 2021-04-08 | ||
| PCT/CN2021/107284 WO2022017363A1 (en) | 2020-07-21 | 2021-07-20 | Compositions and methods for the treatment of ocular diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535232A JP2023535232A (ja) | 2023-08-16 |
| JPWO2022017363A5 JPWO2022017363A5 (https=) | 2024-07-26 |
| JP2023535232A5 true JP2023535232A5 (https=) | 2024-07-26 |
Family
ID=79728991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512465A Withdrawn JP2023535232A (ja) | 2020-07-21 | 2021-07-20 | 眼疾患の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230321280A1 (https=) |
| EP (1) | EP4185335A1 (https=) |
| JP (1) | JP2023535232A (https=) |
| CN (1) | CN116368228A (https=) |
| AU (1) | AU2021314400A1 (https=) |
| CA (1) | CA3186818A1 (https=) |
| WO (1) | WO2022017363A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023187822A1 (en) * | 2022-03-28 | 2023-10-05 | Indian Institute Of Technology Kanpur | A system for an ocular gene therapy and a process for preparing thereof |
| WO2024077089A2 (en) * | 2022-10-04 | 2024-04-11 | Siren Biotechnology, Inc. | Modified cpg dinucleotides for recombinant viral vector production |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201502137D0 (en) * | 2015-02-09 | 2015-03-25 | Ucl Business Plc | Treatment |
| US20180161405A1 (en) * | 2015-06-04 | 2018-06-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Improved methods for treating ocular diseases by gene therapy |
| KR20200036912A (ko) * | 2017-07-31 | 2020-04-07 | 리플렉션 바이오테크놀러지스 리미티드 | 안과 질환을 위한 세포 모델 및 치료요법 |
| CN111118017B (zh) * | 2018-11-01 | 2023-10-03 | 上海朗昇生物科技有限公司 | 治疗Leber先天性黑蒙症的载体及其应用 |
-
2021
- 2021-07-20 WO PCT/CN2021/107284 patent/WO2022017363A1/en not_active Ceased
- 2021-07-20 AU AU2021314400A patent/AU2021314400A1/en not_active Abandoned
- 2021-07-20 JP JP2023512465A patent/JP2023535232A/ja not_active Withdrawn
- 2021-07-20 CN CN202180064406.4A patent/CN116368228A/zh active Pending
- 2021-07-20 CA CA3186818A patent/CA3186818A1/en active Pending
- 2021-07-20 EP EP21846029.3A patent/EP4185335A1/en not_active Withdrawn
-
2023
- 2023-01-20 US US18/157,577 patent/US20230321280A1/en active Pending